001     136511
005     20240321220101.0
024 7 _ |a 10.1096/fj.11-191023
|2 doi
024 7 _ |a pmid:22278939
|2 pmid
024 7 _ |a 0892-6638
|2 ISSN
024 7 _ |a 1530-6860
|2 ISSN
037 _ _ |a DZNE-2020-02833
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Sartorius, Tina
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Toll-like receptors 2 and 4 impair insulin-mediated brain activity by interleukin-6 and osteopontin and alter sleep architecture.
260 _ _ |a Bethesda, Md.
|c 2012
|b FASEB
264 _ 1 |3 online
|2 Crossref
|b Wiley
|c 2012-01-25
264 _ 1 |3 print
|2 Crossref
|b Wiley
|c 2012-05-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1585653304_17219
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Impaired insulin action in the brain represents an early step in the progression toward type 2 diabetes, and elevated levels of saturated free fatty acids are known to impair insulin action in prediabetic subjects. One potential mediator that links fatty acids to inflammation and insulin resistance is the Toll-like receptor (TLR) family. Therefore, C3H/HeJ/TLR2-KO (TLR2/4-deficient) mice were fed a high-fat diet (HFD), and insulin action in the brain as well as cortical and locomotor activity was analyzed by using telemetric implants. TLR2/4-deficient mice were protected from HFD-induced glucose intolerance and insulin resistance in the brain and displayed an improvement in cortical and locomotor activity that was not observed in C3H/HeJ mice. Sleep recordings revealed a 42% increase in rapid eye movement sleep in the deficient mice during daytime, and these mice spent 41% more time awake during the night period. Treatment of control mice with a neutralizing IL-6 antibody improved insulin action in the brain as well as cortical activity and diminished osteopontin protein to levels of the TLR2/4-deficient mice. Together, our data suggest that the lack of functional TLR2/4 protects mice from a fat-mediated impairment in insulin action, brain activity, locomotion, and sleep architecture by an IL-6/osteopontin-dependent mechanism.
536 _ _ |a 345 - Population Studies and Genetics (POF3-345)
|0 G:(DE-HGF)POF3-345
|c POF3-345
|f POF III
|x 0
542 _ _ |i 2012-01-25
|2 Crossref
|u http://onlinelibrary.wiley.com/termsAndConditions#vor
542 _ _ |i 2012-01-25
|2 Crossref
|u http://doi.wiley.com/10.1002/tdm_license_1.1
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Insulin
|2 NLM Chemicals
650 _ 7 |a Interleukin-6
|2 NLM Chemicals
650 _ 7 |a Tlr2 protein, mouse
|2 NLM Chemicals
650 _ 7 |a Tlr4 protein, mouse
|2 NLM Chemicals
650 _ 7 |a Toll-Like Receptor 2
|2 NLM Chemicals
650 _ 7 |a Toll-Like Receptor 4
|2 NLM Chemicals
650 _ 7 |a Osteopontin
|0 106441-73-0
|2 NLM Chemicals
650 _ 7 |a Proto-Oncogene Proteins c-akt
|0 EC 2.7.11.1
|2 NLM Chemicals
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Astrocytes: metabolism
|2 MeSH
650 _ 2 |a Brain: physiology
|2 MeSH
650 _ 2 |a Cells, Cultured
|2 MeSH
650 _ 2 |a Electroencephalography
|2 MeSH
650 _ 2 |a Glucose Tolerance Test
|2 MeSH
650 _ 2 |a Insulin: physiology
|2 MeSH
650 _ 2 |a Insulin Resistance
|2 MeSH
650 _ 2 |a Interleukin-6: immunology
|2 MeSH
650 _ 2 |a Interleukin-6: physiology
|2 MeSH
650 _ 2 |a Locomotion
|2 MeSH
650 _ 2 |a Mice
|2 MeSH
650 _ 2 |a Mice, Inbred C3H
|2 MeSH
650 _ 2 |a Mice, Knockout
|2 MeSH
650 _ 2 |a Osteopontin: physiology
|2 MeSH
650 _ 2 |a Phosphorylation
|2 MeSH
650 _ 2 |a Proto-Oncogene Proteins c-akt: metabolism
|2 MeSH
650 _ 2 |a Real-Time Polymerase Chain Reaction
|2 MeSH
650 _ 2 |a Sleep
|2 MeSH
650 _ 2 |a Toll-Like Receptor 2: genetics
|2 MeSH
650 _ 2 |a Toll-Like Receptor 2: physiology
|2 MeSH
650 _ 2 |a Toll-Like Receptor 4: genetics
|2 MeSH
650 _ 2 |a Toll-Like Receptor 4: physiology
|2 MeSH
700 1 _ |a Lutz, Stefan Z
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Hoene, Miriam
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Waak, Jens
|0 P:(DE-2719)9000332
|b 3
|u dzne
700 1 _ |a Peter, Andreas
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Weigert, Cora
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Rammensee, Hans-Georg
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Kahle, Philipp J
|0 P:(DE-2719)2810803
|b 7
|u dzne
700 1 _ |a Häring, Hans-Ulrich
|0 P:(DE-HGF)0
|b 8
|e Corresponding author
700 1 _ |a Hennige, Anita M
|0 P:(DE-HGF)0
|b 9
773 1 8 |a 10.1096/fj.11-191023
|b : Wiley, 2012-01-25
|n 5
|p 1799-1809
|3 journal-article
|2 Crossref
|t The FASEB Journal
|v 26
|y 2012
|x 0892-6638
773 _ _ |a 10.1096/fj.11-191023
|g Vol. 26, no. 5, p. 1799 - 1809
|0 PERI:(DE-600)1468876-1
|n 5
|q 26:5<1799 - 1809
|p 1799-1809
|t The FASEB journal
|v 26
|y 2012
|x 0892-6638
909 C O |o oai:pub.dzne.de:136511
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)9000332
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-2719)2810803
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-345
|2 G:(DE-HGF)POF3-300
|v Population Studies and Genetics
|x 0
914 1 _ |y 2012
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b FASEB J : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b FASEB J : 2017
920 1 _ |0 I:(DE-2719)1210000-4
|k AG Kahle 2
|l Functional Neurogenetics
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1210000-4
980 _ _ |a UNRESTRICTED
999 C 5 |a 10.2337/diab.46.6.1001
|9 -- missing cx lookup --
|2 Crossref
|o 10.2337/diab.46.6.1001
999 C 5 |a 10.1002/1522-2594(200102)45:2<179::AID-MRM1023>3.0.CO;2-D
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/1522-2594(200102)45:2<179::AID-MRM1023>3.0.CO;2-D
999 C 5 |a 10.1172/JCI118742
|9 -- missing cx lookup --
|2 Crossref
|o 10.1172/JCI118742
999 C 5 |a 10.2337/diabetes.50.11.2579
|9 -- missing cx lookup --
|2 Crossref
|o 10.2337/diabetes.50.11.2579
999 C 5 |a 10.1038/nri2925
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nri2925
999 C 5 |a 10.1016/j.tem.2005.01.008
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.tem.2005.01.008
999 C 5 |a 10.1172/JCI22217
|9 -- missing cx lookup --
|2 Crossref
|o 10.1172/JCI22217
999 C 5 |a 10.1073/pnas.0604404103
|9 -- missing cx lookup --
|2 Crossref
|o 10.1073/pnas.0604404103
999 C 5 |a 10.1007/s00125-007-0839-1
|9 -- missing cx lookup --
|2 Crossref
|o 10.1007/s00125-007-0839-1
999 C 5 |a 10.1007/s00125-008-1187-5
|9 -- missing cx lookup --
|2 Crossref
|o 10.1007/s00125-008-1187-5
999 C 5 |a 10.1210/jc.2009-0469
|9 -- missing cx lookup --
|2 Crossref
|o 10.1210/jc.2009-0469
999 C 5 |a 10.1007/s00125-009-1522-5
|9 -- missing cx lookup --
|2 Crossref
|o 10.1007/s00125-009-1522-5
999 C 5 |a 10.1097/MOL.0b013e32832fa5c4
|9 -- missing cx lookup --
|2 Crossref
|o 10.1097/MOL.0b013e32832fa5c4
999 C 5 |a 10.1016/j.tem.2010.08.007
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.tem.2010.08.007
999 C 5 |a 10.2337/db06-1595
|9 -- missing cx lookup --
|2 Crossref
|o 10.2337/db06-1595
999 C 5 |a 10.1007/s00125-007-0654-8
|9 -- missing cx lookup --
|2 Crossref
|o 10.1007/s00125-007-0654-8
999 C 5 |a 10.2337/db09-1907
|9 -- missing cx lookup --
|2 Crossref
|o 10.2337/db09-1907
999 C 5 |a 10.1038/ni.1863
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/ni.1863
999 C 5 |a 10.1172/JCI31986
|9 -- missing cx lookup --
|2 Crossref
|o 10.1172/JCI31986
999 C 5 |a 10.1074/jbc.M109.033951
|9 -- missing cx lookup --
|2 Crossref
|o 10.1074/jbc.M109.033951
999 C 5 |a 10.1126/science.1167571
|9 -- missing cx lookup --
|2 Crossref
|o 10.1126/science.1167571
999 C 5 |a 10.1001/jama.286.3.327
|9 -- missing cx lookup --
|2 Crossref
|o 10.1001/jama.286.3.327
999 C 5 |a 10.2337/diabetes.53.7.1773
|9 -- missing cx lookup --
|2 Crossref
|o 10.2337/diabetes.53.7.1773
999 C 5 |a 10.1210/jc.83.5.1573
|9 -- missing cx lookup --
|2 Crossref
|o 10.1210/jc.83.5.1573
999 C 5 |a 10.1371/journal.pbio.1001212
|9 -- missing cx lookup --
|2 Crossref
|o 10.1371/journal.pbio.1001212
999 C 5 |a 10.1152/ajprenal.00383.2007
|9 -- missing cx lookup --
|2 Crossref
|o 10.1152/ajprenal.00383.2007
999 C 5 |a 10.1172/JCI18581
|9 -- missing cx lookup --
|2 Crossref
|o 10.1172/JCI18581
999 C 5 |a 10.2337/diabetes.54.2.361
|9 -- missing cx lookup --
|2 Crossref
|o 10.2337/diabetes.54.2.361
999 C 5 |a 10.1016/0076-6879(85)09097-8
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/0076-6879(85)09097-8
999 C 5 |a 10.1046/j.1365-2869.1999.00158.x
|9 -- missing cx lookup --
|2 Crossref
|o 10.1046/j.1365-2869.1999.00158.x
999 C 5 |a 10.1371/journal.pbio.1000465
|9 -- missing cx lookup --
|2 Crossref
|o 10.1371/journal.pbio.1000465
999 C 5 |a 10.1371/journal.pone.0019482
|9 -- missing cx lookup --
|2 Crossref
|o 10.1371/journal.pone.0019482
999 C 5 |a 10.1073/pnas.0308724101
|9 -- missing cx lookup --
|2 Crossref
|o 10.1073/pnas.0308724101
999 C 5 |a 10.1126/science.1142179
|9 -- missing cx lookup --
|2 Crossref
|o 10.1126/science.1142179
999 C 5 |a 10.1016/j.tins.2008.01.005
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.tins.2008.01.005
999 C 5 |a 10.1523/JNEUROSCI.2760-08.2009
|9 -- missing cx lookup --
|2 Crossref
|o 10.1523/JNEUROSCI.2760-08.2009
999 C 5 |a 10.1210/en.2010-0659
|9 -- missing cx lookup --
|2 Crossref
|o 10.1210/en.2010-0659
999 C 5 |a 10.1172/JCI17645
|9 -- missing cx lookup --
|2 Crossref
|o 10.1172/JCI17645
999 C 5 |a 10.1016/j.mce.2003.08.003
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.mce.2003.08.003
999 C 5 |a 10.1016/j.cmet.2011.02.010
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.cmet.2011.02.010
999 C 5 |a 10.1038/nm0102-75
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nm0102-75
999 C 5 |a 10.1152/ajpendo.00189.2003
|9 -- missing cx lookup --
|2 Crossref
|o 10.1152/ajpendo.00189.2003
999 C 5 |a 10.1073/pnas.0801059105
|9 -- missing cx lookup --
|2 Crossref
|o 10.1073/pnas.0801059105
999 C 5 |a 10.2337/db09-0404
|9 -- missing cx lookup --
|2 Crossref
|o 10.2337/db09-0404
999 C 5 |a 10.2337/db08-0400
|9 -- missing cx lookup --
|2 Crossref
|o 10.2337/db08-0400
999 C 5 |a 10.1371/journal.pone.0013959
|9 -- missing cx lookup --
|2 Crossref
|o 10.1371/journal.pone.0013959
999 C 5 |a 10.1212/WNL.0b013e3181d3e44b
|9 -- missing cx lookup --
|2 Crossref
|o 10.1212/WNL.0b013e3181d3e44b
999 C 5 |a 10.1371/journal.pone.0021594
|9 -- missing cx lookup --
|2 Crossref
|o 10.1371/journal.pone.0021594
999 C 5 |a 10.1016/j.bbi.2008.02.001
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.bbi.2008.02.001


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21